Lead exposure changes the expression and function of cannabinoid receptors CB1 and CB2, reducing CB1 density in brain regions important for cognition and upregulating CB2 in immune cells, contributing to neuroinflammation and cognitive deficits. This evidence concerns the gene CNR2 and Cognitive impairment.